Emergent BioSolutions (EBS) Current Deferred Tax Assets (2010 - 2015)

Emergent BioSolutions' Current Deferred Tax Assets history runs 6 years deep, the most recent figure standing at $1.5 million for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets changed N/A year-over-year to $1.5 million; the TTM figure through Sep 2015 stood at $1.5 million (changed N/A YoY), while the FY2014 annual figure was $1.7 million, changed N/A from the prior year.
• Current Deferred Tax Assets was $1.5 million for Q3 2015 at Emergent BioSolutions, roughly flat from $1.5 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $7.2 million in Q3 2011 to a low of $327000.0 in Q3 2012.
• Historically, Current Deferred Tax Assets has averaged $2.1 million across 5 years, with a median of $1.4 million in 2012.
• The sharpest annual moves came in 2012 and 2013: Current Deferred Tax Assets plunged 95.46% in 2012, then jumped 286.54% in 2013.
• A 5-year view of Current Deferred Tax Assets shows it stood at $1.7 million in 2011, then slipped by 27.15% to $1.3 million in 2012, then changed by 0.0% to $1.3 million in 2013, then surged by 35.28% to $1.7 million in 2014, then dropped by 13.27% to $1.5 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $1.5 million (Q3 2015), $1.5 million (Q2 2015), and $1.7 million (Q1 2015), per Business Quant data.